Sale

Guillain-Barre Syndrome Treatment Market

Global Guillain-Barre Syndrome Treatment Market Share, Size, Trends: By Treatment: Intravenous Immunoglobulin, Plasma Exchange, Others; By Route of Administration: Oral, Parental; By Distribution Channels:Hospital Pharmacies, Retail Pharmacies, Others; Regional Analysis;Competitive Landscape: Industry Events and Developments; 2024-2032

Global Guillain-Barre Syndrome Treatment Market Outlook 

The global Guillain-Barre syndrome treatment market is estimated to grow in the forecast period of 2024-2032 at a CAGR of 5.4%.

 

guillain-barre-syndrome-treatment-market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Hold a Substantial Share in the Market Growth of Guillain-Barre Syndrome Treatments

North America is projected to register a substantial share in the Guillain-Barre syndrome treatment market over the forecast period owing to the high number of cases in the region. The presence of a well-established healthcare infrastructure is expected to drive the market growth in North America. The growth would be supplemented by with the growing geriatric population as they are more sensitive to catching infections because of their low immunity that further requiring effective therapy.


Going further, the growing per capita healthcare expenditure along with a huge patient population and changing lifestyles is likely to drive the market. The existence of developed economies like Canada and the United States along with high awareness among end-users and high cost of therapeutic products are expected to fuel regional growth.

 

Market Segmentation

Guillain-Barre syndrome is a rare disorder in which the immune system of the body attacks the nerves. Weakness and tingling in the feet and hands are generally the first symptoms. Such sensations can spread quickly, sooner or later paralysing the whole body. In its most severe form, the syndrome is called a medical emergency. Most people with this disorder must be hospitalised to obtain treatment.

 

guillain-barre-syndrome-treatment-market-by-segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By treatment, the Guillain-Barre syndrome treatment market is divided into:

  • Intravenous Immunoglobulin
  • Plasma Exchange 
  • Others

 

Based on the route of administration, the treatment market is bifurcated into:

  • Oral
  • Parental

 

On the basis of distribution channel, the market is categorised into:

  • Hospital Pharmacies 
  • Retail Pharmacies 
  • Others

 

The EMR report looks into the regional markets of Guillain-Barre syndrome treatment like Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa.

 

guillain-barre-syndrome-treatment-market-by-region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Adoption of Intravenous Immunoglobulin Treatment to Fuel the Market Growth of Guillain-Barre Syndrome Treatment

On the basis of treatments, the intravenous immunoglobulin segment is expected to fuel the market growth over the coming years. This is on account of the growing adoption of treatment by off-label usage of intravenous immunoglobulins owing to the increasing prevalence of dermatomyositis, multifocal motor neuropathy, relapsing-remitting multiple sclerosis, polymyositis, and stiff person syndrome.

 

The accessibility of an extensive range of intravenous immunoglobulin products like Gamunex, Privigen, and Gammagard is expected to drive the growth of the market. Intravenous immunoglobulin is utilised to lower the effects of certain inflammatory conditions that impact the immune system, also known as autoimmune diseases. Moreover, technological advancements in diagnosis and treatment are expected to bolster the market growth across the region during the forecast period.

 

Key Players in the Global Market for Guillain-Barre Syndrome Treatment

The report presents a detailed analysis of the following key players in the global market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

 

  • CSL Behring 
  • Kedrion S.p.A 
  • Cellenkos Inc. 
  • Takeda Pharmaceutical Company Limited. 
  • Hansa Biopharma AB 
  • Others

 

The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment
  • Route of Administration
  • Distribution Channels
  • Region
Breakup by Treatment
  • Intravenous Immunoglobulin
  • Plasma Exchange
  • Others 
Breakup by Route of Administration
  • Oral
  • Parental
Breakup by Distribution Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • CSL Behring
  • Kedrion S.p.A
  • Cellenkos Inc.
  • Takeda Pharmaceutical Company Limited.
  • Hansa Biopharma AB
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Opportunities and Challenges in the Market
8    Global Guillain-Barre Syndrome Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Guillain-Barre Syndrome Treatment Historical Market (2018-2023) 
    8.3    Global Guillain-Barre Syndrome Treatment Market Forecast (2024-2032)
    8.4    Global Guillain-Barre Syndrome Treatment Market by Treatment
        8.4.1    Intravenous Immunoglobulin
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Plasma Exchange
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Others 
    8.5    Global Guillain-Barre Syndrome Treatment Market by Route of Administration
        8.5.1    Oral
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Parental
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
    8.6    Global Guillain-Barre Syndrome Treatment Market by Distribution Channels
        8.6.1    Hospital Pharmacies
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Retail Pharmacies 
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Others
    8.7    Global Guillain-Barre Syndrome Treatment Market by Region       
        8.7.1    North America
            8.7.1.1    Historical Trend (2018-2023) 
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Europe
            8.7.2.1    Historical Trend (2018-2023) 
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Asia Pacific
            8.7.3.1    Historical Trend (2018-2023) 
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Latin America
            8.7.4.1    Historical Trend (2018-2023) 
            8.7.4.2    Forecast Trend (2024-2032)
        8.7.5    Middle East and Africa
            8.7.5.1    Historical Trend (2018-2023) 
            8.7.5.2    Forecast Trend (2024-2032)
9    North America Guillain-Barre Syndrome Treatment Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Guillain-Barre Syndrome Treatment Market Analysis
     10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
     10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
     10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
     10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
     10.5    Others
11    Asia Pacific  Guillain-Barre Syndrome Treatment Market Analysis
     11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
     11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
     11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
     11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
     11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
     11.6    Others
12    Latin America Guillain-Barre Syndrome Treatment Market Analysis
     12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
     12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
     12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
     12.4    Others
13    Middle East and Africa Guillain-Barre Syndrome Treatment Market Analysis
     13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
     13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
     13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
     13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
     13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
       14.1.1    Strengths
       14.1.2    Weaknesses
       14.1.3    Opportunities
       14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
       14.2.1    Supplier’s Power
       14.2.2    Buyer’s Power
       14.2.3    Threat of New Entrants
       14.2.4    Degree of Rivalry
       14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
       15.2.1    CSL Behring
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
       15.2.2    Kedrion S.p.A
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
       15.2.3    Cellenkos Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
       15.2.4    Takeda Pharmaceutical Company Limited.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
       15.2.5    Hansa Biopharma AB
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Guillain-Barre Syndrome Treatment Market: Key Industry Highlights, 2018 and 2032
2.    Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Treatment (USD Million), 2018-2023
3.    Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Treatment (USD Million), 2024-2032
4.    Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Route of Administration (USD Million), 2018-2023
5.    Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Route of Administration (USD Million), 2024-2032
6.    Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Distribution Channels (USD Million), 2018-2023
7.    Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Distribution Channels (USD Million), 2024-2032
8.    Global Guillain-Barre Syndrome Treatment Historical Market: Breakup by Region (USD Million), 2018-2023
9.    Global Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Region (USD Million), 2024-2032
10.    North America Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
11.    North America Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Europe Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Europe Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Asia Pacific Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Asia Pacific Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Latin America Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Latin America Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Middle East and Africa Guillain-Barre Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
19.    Middle East and Africa Guillain-Barre Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
20.    Global Guillain-Barre Syndrome Treatment Market Structure.

Key Questions Answered in the Report

The global market is assessed to grow at a CAGR of 5.4% between 2024 and 2032.

The major market drivers are the growing prevalence of the syndrome and the surging healthcare industry.

The key market trends include huge investments in research and development and the rising usage of IVIG in off-label indications.

The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The various treatments in the market include intravenous immunoglobulin, and plasma exchange, among others.

The major routes of administration in the market include oral and parental.

The various distribution channels in the market include hospital pharmacies and retail pharmacies, among others.

The major players in the market are CSL Behring, Kedrion S.p.A, Cellenkos Inc., Takeda Pharmaceutical Company Limited., and Hansa Biopharma AB, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER